{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:32:34Z","timestamp":1792110754151,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008398","name":"Internationale Stichting Alzheimer Onderzoek","doi-asserted-by":"publisher","award":["15040"],"award-info":[{"award-number":["15040"]}],"id":[{"id":"10.13039\/501100008398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent evidence indicates that disrupted sleep could contribute to the development of Alzheimer\u2019s disease by influencing the production and\/or clearance of the amyloid-\u03b2 protein. We set up a case-control study to investigate the association between long-term work-induced sleep disruption, cognitive function, and brain amyloid-\u03b2 burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Nineteen male maritime pilots (aged 48\u201360\u2009years) with chronic work-related sleep disruption and a sex-, age-, and education-matched control sample (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916, aged 50\u201360\u2009years) with normal sleep completed the study. Primary sleep disorders were ruled out with in-lab polysomnography. Additional sleep measurements were obtained at home using actigraphy, sleep-wake logs, and a single-lead EEG device. Cognitive function was assessed with a neuropsychological test battery, sensitive to early symptomatic Alzheimer\u2019s disease. Brain amyloid-\u03b2 burden was assessed in maritime pilots using\n                      <jats:sup>18<\/jats:sup>\n                      F-flutemetamol amyloid PET-CT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Maritime pilots reported significantly worse sleep quality (Pittsburgh Sleep Quality Index (PSQI)\u2009=\u20098.8\u2009\u00b1\u20092.9) during work weeks, compared to controls (PSQI\u2009=\u20093.2\u2009\u00b1\u20091.4; 95% CI 0.01 to 2.57;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049). This was confirmed with actigraphy-based sleep efficiency (86% \u00b1\u20093.8 vs. 89.3% \u00b1\u20094.3; 95% CI 0.43 to 6.03;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03). Home-EEG recordings showed less total sleep time (TST) and deep sleep time (DST) during work weeks compared to rest weeks (TST 318.56 (250.21\u2013352.93) vs. TST 406.17 (340\u2013425.98);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; DST 36.75 (32.30\u201358.58) vs. DST 51.34 (48.37\u201369.30);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005)). There were no differences in any of the cognitive domains between the groups. For brain amyloid-\u03b2 levels, mean global cortical standard uptake value ratios of\n                      <jats:sup>18<\/jats:sup>\n                      F-flutemetamol were all in the normal range (1.009\u2009\u00b1\u20090.059; 95% CI 0.980 to 1.037), confirmed by visual reads.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Capitalizing on the particular work-rest schedule of maritime pilots, this study with a small sample size observed that long-term intermittent sleep disruption had no effects on global brain amyloid-\u03b2 levels or cognitive function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00668-5","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T10:13:46Z","timestamp":1598436826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of long-term sleep disruption on cognitive function and brain amyloid-\u03b2 burden: a case-control study"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-7369","authenticated-orcid":false,"given":"Jana","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Ooms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara J.","family":"Mentink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G. M.","family":"Olde Rikkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Overeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy P. C.","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen A. H. R.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"1","key":"668_CR1","first-page":"zsw032","volume":"40","author":"OM Bubu","year":"2016","unstructured":"Bubu OM, Brannick M, Mortimer J, Umasabor-Bubu O, Sebasti\u00e3o YV, Wen Y, et al. Sleep, cognitive impairment, and Alzheimer\u2019s disease: a systematic review and meta-analysis. Sleep. 2016;40(1):zsw032.","journal-title":"Sleep"},{"issue":"8","key":"668_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tins.2016.05.002","volume":"39","author":"BA Mander","year":"2016","unstructured":"Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer\u2019s disease? Trends Neurosci. 2016;39(8):552\u201366.","journal-title":"Trends Neurosci"},{"issue":"4","key":"668_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S1041610216002131","volume":"29","author":"AP Spira","year":"2017","unstructured":"Spira AP, Gottesman RF. Sleep disturbance: an emerging opportunity for Alzheimer\u2019s disease prevention? Int Psychogeriatr. 2017;29(4):529\u201331.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"668_CR4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.arr.2012.04.003","volume":"12","author":"D Slats","year":"2013","unstructured":"Slats D, Claassen JA, Verbeek MM, Overeem S. Reciprocal interactions between sleep, circadian rhythms and Alzheimer\u2019s disease: focus on the role of hypocretin and melatonin. Ageing Res Rev. 2013;12(1):188\u2013200.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"668_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"Y-ES Ju","year":"2014","unstructured":"Ju Y-ES, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology [mdash] a bidirectional relationship. Nat Rev Neurol. 2014;10(2):115\u20139.","journal-title":"Nat Rev Neurol"},{"key":"668_CR6","doi-asserted-by":"crossref","unstructured":"Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, et al. Disruption of the sleep-wake cycle and diurnal fluctuation of \u03b2-amyloid in mice with Alzheimer\u2019s disease pathology. Sci Transl Med. 2012;4(150):150ra22-ra22.","DOI":"10.1126\/scitranslmed.3004291"},{"issue":"5955","key":"668_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"J-E Kang","year":"2009","unstructured":"Kang J-E, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science (80- ). 2009;326(5955):1005\u20137.","journal-title":"Science (80- )"},{"key":"668_CR8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neulet.2017.05.054","volume":"653","author":"EN Minakawa","year":"2017","unstructured":"Minakawa EN, Miyazaki K, Maruo K, Yagihara H, Fujita H, Wada K, et al. Chronic sleep fragmentation exacerbates amyloid \u03b2 deposition in Alzheimer\u2019s disease model mice. Neurosci Lett. 2017;653:362\u20139.","journal-title":"Neurosci Lett"},{"key":"668_CR9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2013.07.010","volume":"1529","author":"SM Rothman","year":"2013","unstructured":"Rothman SM, Herdener N, Frankola KA, Mughal MR, Mattson MP. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical A\u03b2 and pTau in a mouse model of Alzheimer\u2019s disease. Brain Res. 2013;1529:200\u20138.","journal-title":"Brain Res"},{"issue":"3","key":"668_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cns.12667","volume":"23","author":"HY Zhao","year":"2017","unstructured":"Zhao HY, Wu HJ, He JL, Zhuang JH, Liu ZY, Huang LQ, et al. Chronic sleep restriction induces cognitive deficits and cortical beta-amyloid deposition in mice via BACE 1-antisense activation. CNS Neurosci Ther. 2017;23(3):233\u201340.","journal-title":"CNS Neurosci Ther"},{"issue":"8","key":"668_CR11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","volume":"71","author":"S Ooms","year":"2014","unstructured":"Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JA. Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA neurology. 2014;71(8):971\u20137.","journal-title":"JAMA neurology."},{"issue":"8","key":"668_CR12","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"Y-ES Ju","year":"2017","unstructured":"Ju Y-ES, Ooms SJ, Sutphen C, Macauley SL, Zangrilli MA, Jerome G, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-\u03b2 levels. Brain. 2017;140(8):2104\u201311.","journal-title":"Brain."},{"issue":"17","key":"668_CR13","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1073\/pnas.1721694115","volume":"115","author":"E Shokri-Kojori","year":"2018","unstructured":"Shokri-Kojori E, Wang G-J, Wiers CE, Demiral SB, Guo M, Kim SW, et al. \u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci. 2018;115(17):4483\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"6156","key":"668_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science (80- ). 2013;342(6156):373\u20137.","journal-title":"Science (80- )"},{"key":"668_CR15","doi-asserted-by":"crossref","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra11-ra11.","DOI":"10.1126\/scitranslmed.3003748"},{"issue":"6140","key":"668_CR16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1240514","volume":"340","author":"M Nedergaard","year":"2013","unstructured":"Nedergaard M. Garbage truck of the brain. Science (80- ). 2013;340(6140):1529\u201330.","journal-title":"Science (80- )"},{"issue":"6465","key":"668_CR17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.aax5440","volume":"366","author":"NE Fultz","year":"2019","unstructured":"Fultz NE, Bonmassar G, Setsompop K, Stickgold RA, Rosen BR, Polimeni JR, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science (80- ). 2019;366(6465):628\u201331.","journal-title":"Science (80- )"},{"issue":"12","key":"668_CR18","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The glymphatic system: a beginner\u2019s guide. Neurochem Res. 2015;40(12):2583\u201399.","journal-title":"Neurochem Res"},{"issue":"2","key":"668_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.9758\/cpn.2017.15.2.89","volume":"15","author":"DW Kang","year":"2017","unstructured":"Kang DW, Lee CU, Lim HK. Role of sleep disturbance in the trajectory of Alzheimer\u2019s disease. Clin Psychopharmacol Neurosci. 2017;15(2):89.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"668_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.25117","volume":"83","author":"BP Lucey","year":"2018","unstructured":"Lucey BP, Hicks TJ, McLeland JS, Toedebusch CD, Boyd J, Elbert DL, et al. Effect of sleep on overnight cerebrospinal fluid amyloid \u03b2 kinetics. Ann Neurol. 2018;83(1):197\u2013204.","journal-title":"Ann Neurol"},{"issue":"2","key":"668_CR21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"issue":"6","key":"668_CR22","volume":"9","author":"J Thomas","year":"2019","unstructured":"Thomas J, Ooms S, Verbeek M, Booij J, Rijpkema M, Kessels RPC, et al. Sleep-Cognition Hypothesis In maritime Pilots, what is the effect of long-term work-related poor sleep on cognition and amyloid accumulation in healthy middle-aged maritime pilots: methodology of a case\u2013control study. BMJ Open. 2019;9(6):e026992.","journal-title":"BMJ Open"},{"key":"668_CR23","volume-title":"Closed-loop system to enhance slow wave activity during sleep","author":"G Garcia-Molina","year":"2018","unstructured":"Garcia-Molina G, Tsoneva T, Jasko J, Steele B, Aquino A, Baher K, et al. Closed-loop system to enhance slow wave activity during sleep. 2018."},{"key":"668_CR24","first-page":"64","volume":"4","author":"S Weintraub","year":"2018","unstructured":"Weintraub S, Carrillo MC, Farias ST, Goldberg TE, Hendrix JA, Jaeger J, et al. Measuring cognition and function in the preclinical stage of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2018;4:64\u201375.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"668_CR25","unstructured":"Baddeley A, Emslie H, Nimmo-Smith I. Doors and people: a test of visual and verbal recall and recognition, Thames Valley Test Company, Bury St. Edmunds, UK. 1994."},{"issue":"3","key":"668_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"C Curtis","year":"2015","unstructured":"Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA neurology. 2015;72(3):287\u201394.","journal-title":"JAMA neurology."},{"key":"668_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nicl.2017.08.011","volume":"16","author":"VJ Lowe","year":"2017","unstructured":"Lowe VJ, Lundt E, Knopman D, Senjem ML, Gunter JL, Schwarz CG, et al. Comparison of [18F] Flutemetamol and [11C] Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer\u2019s disease dementia individuals. NeuroImage: Clinical. 2017;16:295\u2013302.","journal-title":"NeuroImage: Clinical"},{"issue":"11","key":"668_CR28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"668_CR29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jnc.13838","volume":"139","author":"J Pannee","year":"2016","unstructured":"Pannee J, Portelius E, Minthon L, Gobom J, Andreasson U, Zetterberg H, et al. Reference measurement procedure for CSF amyloid beta (A\u03b2) 1\u201342 and the CSF A\u03b21\u201342\/A\u03b21\u201340 ratio\u2013a cross-validation study against amyloid PET. J Neurochem. 2016;139(4):651\u20138.","journal-title":"J Neurochem"},{"issue":"10","key":"668_CR30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","volume":"71","author":"S Palmqvist","year":"2014","unstructured":"Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA neurology. 2014;71(10):1282\u20139.","journal-title":"JAMA neurology"},{"issue":"14","key":"668_CR31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","volume":"85","author":"S Palmqvist","year":"2015","unstructured":"Palmqvist S, Zetterberg H, Mattsson N, Johansson P, Minthon L, Blennow K, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology. 2015;85(14):1240\u20139.","journal-title":"Neurology."},{"issue":"1","key":"668_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-017-0260-z","volume":"9","author":"FB Bouall\u00e8gue","year":"2017","unstructured":"Bouall\u00e8gue FB, Mariano-Goulart D, Payoux P, Initiative AsDN. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer\u2019s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Alzheimers Res Ther. 2017;9(1):32.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"668_CR33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13195-019-0561-5","volume":"11","author":"J Reimand","year":"2019","unstructured":"Reimand J, De Wilde A, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, et al. PET and CSF amyloid-\u03b2 status are differently predicted by patient features: information from discordant cases. Alzheimers Res Ther. 2019;11(1):100.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"668_CR34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825\u201341.","journal-title":"Neuroimage."},{"issue":"2","key":"668_CR35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. Fsl Neuroimage. 2012;62(2):782\u201390.","journal-title":"Fsl Neuroimage"},{"key":"668_CR36","unstructured":"Andersson JL, Jenkinson M, Smith S. Non-linear registration aka Spatial normalisation FMRIB Technial Report TR07JA2. FMRIB Analysis Group of the University of Oxford 2007."},{"issue":"6","key":"668_CR37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00259-019-04282-y","volume":"46","author":"G Farrar","year":"2019","unstructured":"Farrar G, Molinuevo JL, Zanette M. Is there a difference in regional read [18 F] flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment? Eur J Nucl Med Mol Imaging. 2019;46(6):1299\u2013308.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"668_CR38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68(3):319\u201329.","journal-title":"Ann Neurol"},{"issue":"1\u20134","key":"668_CR39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000335381","volume":"10","author":"L Thurfjell","year":"2012","unstructured":"Thurfjell L, L\u00f6tj\u00f6nen J, Lundqvist R, Koikkalainen J, Soininen H, Waldemar G, et al. Combination of biomarkers: PET [18F] flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neurodegener Dis. 2012;10(1\u20134):246\u20139.","journal-title":"Neurodegener Dis"},{"issue":"3","key":"668_CR40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","volume":"38","author":"CJ Buckley","year":"2017","unstructured":"Buckley CJ, Sherwin PF, Smith AP, Wolber J, Weick SM, Brooks DJ. Validation of an electronic image reader training programme for interpretation of [18F] flutemetamol \u03b2-amyloid PET brain images. Nucl Med Commun. 2017;38(3):234.","journal-title":"Nucl Med Commun"},{"key":"668_CR41","doi-asserted-by":"crossref","unstructured":"Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, et al. Sleep as a potential biomarker of tau and \u03b2-amyloid burden in the human brain. J Neurosci. 2019:0503\u201319.","DOI":"10.1523\/JNEUROSCI.0503-19.2019"},{"issue":"474","key":"668_CR42","doi-asserted-by":"crossref","first-page":"eaau6550","DOI":"10.1126\/scitranslmed.aau6550","volume":"11","author":"BP Lucey","year":"2019","unstructured":"Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, et al. Reduced non\u2013rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease. Sci Transl Med. 2019;11(474):eaau6550.","journal-title":"Sci Transl Med"},{"issue":"7","key":"668_CR43","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn.4035","volume":"18","author":"BA Mander","year":"2015","unstructured":"Mander BA, Marks SM, Vogel JW, Rao V, Lu B, Saletin JM, et al. [beta]-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015;18(7):1051\u20137.","journal-title":"Nat Neurosci"},{"issue":"19","key":"668_CR44","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 2015;313(19):1924\u201338.","journal-title":"Jama."},{"key":"668_CR45","volume-title":"In Alzheimer Research","author":"BM Kuehn","year":"2020","unstructured":"Kuehn BM. In Alzheimer Research. JAMA: Glucose metabolism moves to center stage; 2020."},{"key":"668_CR46","doi-asserted-by":"crossref","unstructured":"Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2000;1502(1):139\u201344.","DOI":"10.1016\/S0925-4439(00)00040-5"},{"issue":"5","key":"668_CR47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","volume":"60","author":"RC Green","year":"2003","unstructured":"Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60(5):753\u20139.","journal-title":"Arch Neurol"},{"key":"668_CR48","doi-asserted-by":"crossref","unstructured":"Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, Pruzin J. Associations of physical activity and \u03b2-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA neurology. 2019;76(10):1203-10.","DOI":"10.1001\/jamaneurol.2019.1879"},{"issue":"1","key":"668_CR49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-180055","volume":"64","author":"TS Lysen","year":"2018","unstructured":"Lysen TS, Wolters FJ, Luik AI, Ikram MK, Tiemeier H, Ikram MA. Subjective sleep quality is not associated with incident dementia: the Rotterdam study. J Alzheimers Dis. 2018;64(1):239\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"6429","key":"668_CR50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth JK, Fritschi SK, Wang C, Pedersen NP, Cirrito JR, Mahan TE, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science (80- ). 2019;363(6429):880\u20134.","journal-title":"Science (80- )"},{"issue":"12","key":"668_CR51","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain."},{"issue":"3","key":"668_CR52","first-page":"748","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain. 2017;140(3):748\u201363.","journal-title":"Brain."},{"issue":"6","key":"668_CR53","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","volume":"92","author":"R Ossenkoppele","year":"2019","unstructured":"Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, et al. Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease. Neurology. 2019;92(6):e601\u2013e12.","journal-title":"Neurology."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00668-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:28:30Z","timestamp":1668029310000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00668-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-24688\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-24688\/v2","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The SCHIP study was approved by the institutional review board (CMO, Commissie Mensgebonden Onderzoek, Region Arnhem-Nijmegen, NL55712.091.16, file number 2016-2337) and performed in accordance with good clinical practice guidelines and the world medical associations code of ethics (Declaration of Helsinki). Written informed consent was obtained from all participants after they received detailed study information. Participants received a stipend of 50 euros for participating; travel costs were compensated.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}